Global Prostate Cancer Nuclear Medicine Diagnostics Market Research Report 2023

Report ID: 2009674 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 SPECT
        1.2.3 PET
    1.3 Market by Application
        1.3.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Perspective (2017-2028)
    2.2 Prostate Cancer Nuclear Medicine Diagnostics Growth Trends by Region
        2.2.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Prostate Cancer Nuclear Medicine Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Prostate Cancer Nuclear Medicine Diagnostics Market Dynamics
        2.3.1 Prostate Cancer Nuclear Medicine Diagnostics Industry Trends
        2.3.2 Prostate Cancer Nuclear Medicine Diagnostics Market Drivers
        2.3.3 Prostate Cancer Nuclear Medicine Diagnostics Market Challenges
        2.3.4 Prostate Cancer Nuclear Medicine Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Revenue
        3.1.1 Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Prostate Cancer Nuclear Medicine Diagnostics Revenue
    3.4 Global Prostate Cancer Nuclear Medicine Diagnostics Market Concentration Ratio
        3.4.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Nuclear Medicine Diagnostics Revenue in 2021
    3.5 Prostate Cancer Nuclear Medicine Diagnostics Key Players Head office and Area Served
    3.6 Key Players Prostate Cancer Nuclear Medicine Diagnostics Product Solution and Service
    3.7 Date of Enter into Prostate Cancer Nuclear Medicine Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Nuclear Medicine Diagnostics Breakdown Data by Type
    4.1 Global Prostate Cancer Nuclear Medicine Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Type (2023-2028)
5 Prostate Cancer Nuclear Medicine Diagnostics Breakdown Data by Application
    5.1 Global Prostate Cancer Nuclear Medicine Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size (2017-2028)
    6.2 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022)
    6.3 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size (2017-2028)
    7.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022)
    7.3 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size (2017-2028)
    9.2 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022)
    9.3 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Blue Earth Diagnostics
        11.1.1 Blue Earth Diagnostics Company Detail
        11.1.2 Blue Earth Diagnostics Business Overview
        11.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Introduction
        11.1.4 Blue Earth Diagnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        11.1.5 Blue Earth Diagnostics Recent Development
    11.2 PETNET Solutions
        11.2.1 PETNET Solutions Company Detail
        11.2.2 PETNET Solutions Business Overview
        11.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Introduction
        11.2.4 PETNET Solutions Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        11.2.5 PETNET Solutions Recent Development
    11.3 Cardinal Health
        11.3.1 Cardinal Health Company Detail
        11.3.2 Cardinal Health Business Overview
        11.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Introduction
        11.3.4 Cardinal Health Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        11.3.5 Cardinal Health Recent Development
    11.4 Lantheus Medical Imaging
        11.4.1 Lantheus Medical Imaging Company Detail
        11.4.2 Lantheus Medical Imaging Business Overview
        11.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Introduction
        11.4.4 Lantheus Medical Imaging Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        11.4.5 Lantheus Medical Imaging Recent Development
    11.5 Jubilant Pharma
        11.5.1 Jubilant Pharma Company Detail
        11.5.2 Jubilant Pharma Business Overview
        11.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
        11.5.4 Jubilant Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        11.5.5 Jubilant Pharma Recent Development
    11.6 NCM-USA
        11.6.1 NCM-USA Company Detail
        11.6.2 NCM-USA Business Overview
        11.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Introduction
        11.6.4 NCM-USA Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        11.6.5 NCM-USA Recent Development
    11.7 Progenics Pharma
        11.7.1 Progenics Pharma Company Detail
        11.7.2 Progenics Pharma Business Overview
        11.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
        11.7.4 Progenics Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        11.7.5 Progenics Pharma Recent Development
    11.8 Telix Pharma
        11.8.1 Telix Pharma Company Detail
        11.8.2 Telix Pharma Business Overview
        11.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
        11.8.4 Telix Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        11.8.5 Telix Pharma Recent Development
    11.9 ImaginAb
        11.9.1 ImaginAb Company Detail
        11.9.2 ImaginAb Business Overview
        11.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Introduction
        11.9.4 ImaginAb Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        11.9.5 ImaginAb Recent Development
    11.10 Theragnostics
        11.10.1 Theragnostics Company Detail
        11.10.2 Theragnostics Business Overview
        11.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Introduction
        11.10.4 Theragnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        11.10.5 Theragnostics Recent Development
    11.11 Novartis
        11.11.1 Novartis Company Detail
        11.11.2 Novartis Business Overview
        11.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Introduction
        11.11.4 Novartis Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        11.11.5 Novartis Recent Development
    11.12 Alliance Medical
        11.12.1 Alliance Medical Company Detail
        11.12.2 Alliance Medical Business Overview
        11.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Introduction
        11.12.4 Alliance Medical Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
        11.12.5 Alliance Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of SPECT
    Table 3. Key Players of PET
    Table 4. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region (2017-2022)
    Table 8. Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region (2023-2028)
    Table 10. Prostate Cancer Nuclear Medicine Diagnostics Market Trends
    Table 11. Prostate Cancer Nuclear Medicine Diagnostics Market Drivers
    Table 12. Prostate Cancer Nuclear Medicine Diagnostics Market Challenges
    Table 13. Prostate Cancer Nuclear Medicine Diagnostics Market Restraints
    Table 14. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Players (2017-2022)
    Table 16. Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Nuclear Medicine Diagnostics as of 2021)
    Table 17. Ranking of Global Top Prostate Cancer Nuclear Medicine Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Prostate Cancer Nuclear Medicine Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Prostate Cancer Nuclear Medicine Diagnostics Product Solution and Service
    Table 21. Date of Enter into Prostate Cancer Nuclear Medicine Diagnostics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Type (2017-2022)
    Table 25. Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Type (2023-2028)
    Table 27. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Application (2017-2022)
    Table 29. Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Application (2023-2028)
    Table 31. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Blue Earth Diagnostics Company Detail
    Table 42. Blue Earth Diagnostics Business Overview
    Table 43. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 44. Blue Earth Diagnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 45. Blue Earth Diagnostics Recent Development
    Table 46. PETNET Solutions Company Detail
    Table 47. PETNET Solutions Business Overview
    Table 48. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 49. PETNET Solutions Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 50. PETNET Solutions Recent Development
    Table 51. Cardinal Health Company Detail
    Table 52. Cardinal Health Business Overview
    Table 53. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 54. Cardinal Health Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 55. Cardinal Health Recent Development
    Table 56. Lantheus Medical Imaging Company Detail
    Table 57. Lantheus Medical Imaging Business Overview
    Table 58. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 59. Lantheus Medical Imaging Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 60. Lantheus Medical Imaging Recent Development
    Table 61. Jubilant Pharma Company Detail
    Table 62. Jubilant Pharma Business Overview
    Table 63. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 64. Jubilant Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 65. Jubilant Pharma Recent Development
    Table 66. NCM-USA Company Detail
    Table 67. NCM-USA Business Overview
    Table 68. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 69. NCM-USA Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 70. NCM-USA Recent Development
    Table 71. Progenics Pharma Company Detail
    Table 72. Progenics Pharma Business Overview
    Table 73. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 74. Progenics Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 75. Progenics Pharma Recent Development
    Table 76. Telix Pharma Company Detail
    Table 77. Telix Pharma Business Overview
    Table 78. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 79. Telix Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 80. Telix Pharma Recent Development
    Table 81. ImaginAb Company Detail
    Table 82. ImaginAb Business Overview
    Table 83. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 84. ImaginAb Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 85. ImaginAb Recent Development
    Table 86. Theragnostics Company Detail
    Table 87. Theragnostics Business Overview
    Table 88. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product
    Table 89. Theragnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 90. Theragnostics Recent Development
    Table 91. Novartis Company Detail
    Table 92. Novartis Business Overview
    Table 93. Novartis Prostate Cancer Nuclear Medicine DiagnosticsProduct
    Table 94. Novartis Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 95. Novartis Recent Development
    Table 96. Alliance Medical Company Detail
    Table 97. Alliance Medical Business Overview
    Table 98. Alliance Medical Prostate Cancer Nuclear Medicine DiagnosticsProduct
    Table 99. Alliance Medical Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
    Table 100. Alliance Medical Recent Development
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. SPECT Features
    Figure 3. PET Features
    Figure 4. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Others Case Studies
    Figure 8. Prostate Cancer Nuclear Medicine Diagnostics Report Years Considered
    Figure 9. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region: 2021 VS 2028
    Figure 12. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Players in 2021
    Figure 13. Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Nuclear Medicine Diagnostics as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Prostate Cancer Nuclear Medicine Diagnostics Revenue in 2021
    Figure 15. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Country (2017-2028)
    Figure 17. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Share by Country (2017-2028)
    Figure 21. Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region (2017-2028)
    Figure 29. China Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Country (2017-2028)
    Figure 37. Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Share by Country (2017-2028)
    Figure 41. Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Blue Earth Diagnostics Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 44. PETNET Solutions Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 45. Cardinal Health Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 46. Lantheus Medical Imaging Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 47. Jubilant Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 48. NCM-USA Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 49. Progenics Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 50. Telix Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 51. ImaginAb Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 52. Theragnostics Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 53. Novartis Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 54. Alliance Medical Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Blue Earth Diagnostics
PETNET Solutions
Cardinal Health
Lantheus Medical Imaging
Jubilant Pharma
NCM-USA
Progenics Pharma
Telix Pharma
ImaginAb
Theragnostics
Novartis
Alliance Medical
Frequently Asked Questions
Prostate Cancer Nuclear Medicine Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate Cancer Nuclear Medicine Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate Cancer Nuclear Medicine Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Medical Writing

Medical Writing market is segmented by players, region (country), by Type and by Application. Pla ... Read More